MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Magnolol

CAS No. : 528-43-8

MCE 站：Magnolol

产品活性：Magnolol 是从厚朴的树皮中分到的木脂素，为 RXRα 和 PPARγ 的双重激动剂，EC₅₀ 值分别为 10.4 ?M 和 17.7 ?M。

研究领域：Metabolic Enzyme/Protease  |  Cell Cycle/DNA Damage  |  Autophagy  |  Anti-infection

作用靶点：RAR/RXR  |  PPAR  |  Autophagy  |  Bacterial

In Vitro: Magnolol is a dual agonist of both RXRα and PPARγ, with EC₅₀ values of 10.4 ?M and 17.7 ?M, respectively. Magnolol (26.2-80 ?M) binds to RXRαLBD and PPARγLBD in a dose dependent manner, with K_d values of 45.7 ?M and 1.67 ?M, respectively. Magnolol (1-20 ?M) induces the transcription of PPRE in a dose-dependent manner, but shows no activity on RXRE transcription. Magnolol (1, 3, 10 ?M) enhances adipocyte differentiation of both 3T3-L1 pre-adipocystes and C3H10T1/2 pluripotent stem cells in the presence of insulin. Magnolol (10 μM) upregulates mRNA expression of marker genes for adipocyte differentiation. Magnolol (1, 10 μM) shows an increase in basal and insulin-stimulated glucose uptake in differentiated 3T3-L1 adipocytes.

In Vivo: Magnolol (5-15 mg/kg, p.o.) significantly attenuates the phenotypic severity of dextran sulfate sodium (DSS)-induced colitis in mice. Magnolol (10, 15 mg/kg, p.o.) attenuates histopathological changes and myeloperoxidase activity in the colon of DSS-treated mice, decreases DSS-induced high levels of proinflammatory cytokines TNF-α, IL-1β and IL-6 in the colonic tissues. Magnolol (10 mg/kg, p.o.) also reverses abnormality of serum metabolome, and regulates tryptophan metabolic pathway in mice.

相关产品：Natural Product Library Plus  |  Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Anti-Infection Compound Library  |  Cell Cycle/DNA Damage Compound Library  |  Immunology/Inflammation Compound Library  |  Metabolism/Protease Compound Library  |  Natural Product Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Autophagy Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Differentiation Inducing Compound Library  |  Reprogramming Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  Antibacterial Compound Library  |  NMPA-Approved Drug Library  |  Pyroptosis Compound Library  |  Traditional Chinese Medicine Monomer Library  |  FDA Approved & Pharmacopeial Drug Library  |  Doxorubicin hydrochloride  |  Bafilomycin A1  |  Puromycin dihydrochloride  |  Staurosporine  |  Dexamethasone  |  Doxycycline (hyclate)  |  Actinomycin D  |  G-418 disulfate  |  5-Azacytidine  |  Etoposide  |  Mitomycin C  |  CCCP  |  Retinoic acid  |  Nigericin sodium salt  |  Rosiglitazone  |  Resveratrol  |  Tunicamycin  |  Hygromycin B  |  GW9662  |  Tacrolimus  |  Ionomycin  |  Vancomycin hydrochloride  |  Streptozocin  |  Tanespimycin  |  Anisomycin  |  Neomycin sulfate  |  Ampicillin sodium  |  Geldanamycin  |  Auranofin  |  Daunorubicin hydrochloride

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。